MedTrace Logo

Telemetric Glucose Data Acquisition During Initiation of Insulin Pump Therapy

NCT00297635 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2017-01-12

No results posted yet for this study

Summary

This study will help determine whether the use of a wireless glucose meter and and an internet-based automated diabetes management system to organize blood glucose values will help improve glucose control during the start of continuous subcutaneous insulin infusion therapy by an insulin pump device in patients with type 1 diabetes. Outcome measures to be determined include an assessment of glucose excursions, overall glucose control, health care team staff and patient time required and a satisfaction survey.

Conditions

  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Insulin-Dependent

Interventions

DEVICE

GlucoDYNAMIX™ intervention system

DEVICE

GlucoMON™ telemetry device

Sponsors & Collaborators

  • LifeScan

    collaborator INDUSTRY

  • Diabetech

    collaborator INDUSTRY

  • Thomas Jefferson University

    lead OTHER

Principal Investigators

  • Barry J. Goldstein, MD, PhD · Thomas Jefferson University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Completion
2007-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00297635 on ClinicalTrials.gov